logo BDSP

Base documentaire


  1. The use of methylphenidate in Michigan.

    Article - En anglais

    Objective 

    To describe the epidemiologic findings associated with the use of methylphenidate hydrochloride among children aged 0 to 19 years in Michigan.

    Design 

    A population-based data set of all prescriptions filed with the Michigan Triplicate Prescription Program during February and March 1992 was analyzed, maintaining complete anonymity.

    Setting 

    State of Michigan.

    Participants 

    All patients receiving a prescription for methylphenidate who are residents of Michigan, and all physicians prescribing methylphenidate.

    Interventions 

    None.

    Main Outcome Measures 

    Descriptive data.

    Results 

    Eleven of 1000 Michigan residents between the ages of 0 and 19 years received a prescription for methylphenidate during the study period.

    Eighty-four percent were boys.

    Boys aged 10 or 11 years received more prescriptions for methylphenidate than any other age group-43 per 1000.

    The number of children receiving prescriptions for methylphenidate ranged from 2.5 to 28 per 1000.

    The range for boys aged 10 or 11 years was from 9.6 to 117 per 1000.

    Primary care physicians wrote 84% of all prescriptions ; pediatricians wrote 59% of the prescriptions for patients younger than 20 years old.

    Half of the prescriptions written by pediatricians were written by 5% of the pediatricians in the state.

    Conclusions 

    Michigan has been among the states with the highest per capita consumption of methylphenidate for the past 10 years.

    Mots-clés Pascal : Trouble fonctionnel minime encéphale, Enfant, Homme, Traitement, Chimiothérapie, Consommation, Méthylphénidate, Adolescent, Nourrisson, Epidémiologie, Michigan, Etats Unis, Amérique du Nord, Amérique, Psychotrope, Stimulant SNC, Trouble attention, Hyperactivité

    Mots-clés Pascal anglais : Hyperactive child syndrome, Child, Human, Treatment, Chemotherapy, Consumption, Adolescent, Infant, Epidemiology, Michigan, United States, North America, America, Psychotropic, CNS stimulant, Attentional disorder, Hyperactivity

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0364705

    Code Inist : 002B02B02. Création : 01/03/1996.